Cited by 20Chronic Kidney Disease and DiabetesDiabetes Treatment and ManagementDiabetes Management and Research

Intensive glycemic control improves long-term renal outcomes in type 2 diabetes in the Veterans Affairs Diabetes Trial (VADT)

Open access
Agrawal, Lily, Azad, Nasrin, Bahn, Gideon D., Reaven, Peter D., Hayward, Rodney A., Reda, Domenic J., Emanuele, Nicholas V., VADT Study Group +278 more·2019·Diabetes Care

Abstract

Diabetes accounts for almost 50% of cases of end-stage renal disease (ESRD) in high-income countries (1). Although the impact of intensive glycemic control on macrovascular complications is relatively modest, evidence suggests that tight glucose control may reduce kidney disease progression. The role of glucose control in preventing chronic kidney disease and ESRD continues to be of significant interest. The Veterans Affairs Diabetes Trial (VADT) was a randomized, prospective, multicenter study in 1,791 veterans with poorly controlled type 2 diabetes, primarily to determine the impact of 5.6 years of tight versus standard glycemic control on cardiovascular events; secondary outcomes included microvascular disease. After the 5.6-year interventional period, the cohort was observationally followed for an additional 10 years (median follow-up was 15 years, ending in 2017) and provided a unique view of the impact of glycemic control on important clinical outcomes. As previously reported, baseline demographics, clinical characteristics, statin and blood pressure medicine use, and mean HbA1c (9.4 ± 2% [79.2 mmol/mol]) were balanced between the two groups (2). Participants received either intensive (INT) or standard (STD) glucose control for a median of 5.6 years. The median HbA1c achieved was 1.5% lower in INT versus STD during the intervention phase (6.9% vs. 8.4% [52 vs. 68 mmol/mol]). Subsequent diabetes care was provided by their primary health care team, and participants were followed using the Department of Veterans …

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc19-0891

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The ADVANCE and VADT trials found modest reduction in nephropathy with intensive glycemic management; ACCORD was stopped after a median of 3.5 years due to higher mortality in the intervention arm.

    “The ADVANCE and VADT trials found modest reduction in nephropathy with intensive glycemic management; ACCORD was stopped after a median of 3.5 years due to higher mortality in the intervention arm (51-55).”

    From 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026. (2026) · cites this paper as [55]

    The VADT results section (page not provided) reports a 19% reduction in a composite renal outcome with intensive glycemic control at 15 years, supporting the VADT portion of the sentence. The paper does not report the ADVANCE nephropathy finding or the claim that ACCORD was stopped after a median of 3.5 years because of higher mortality. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 5 · Cited by 20

Authors
Agrawal, L., Azad, N., Bahn, G. D., Reaven, P. D., Hayward, R. A., Reda, D. J., Emanuele, N. V., VADT Study Group, Abraira, C., Duckworth, W. C., Hayden, C. T., Paul, C., Arca, D., Zolotor, R. M., Williams, L., Hayden, C. T., Collier, S. L., Ahmed, N., Boyd, A., Reda, D., Moritz, T., Anderson, R., Vitek, M. E., Paine, T., Thottapurathu, L., Luo, P., Bukowski, K., Motyka, D., Barillas, V., Brown, R., Christine, B., Anfinsen, L., Biondic, M., Havlicek, R., Kubal, J., McAuliffe, M., McCarren, M., Rachelle, M., Rose, L., Sacks, J., Sindowski, T., Thomas, J., Zahora, C., Sather, M. R., Day, J., Haroldson, J., Abraira, C., Duckworth, W., Davis, S. N., Emanuele, N., Goldman, S., Hayward, R., Marks, J., Moritz, T., Reaven, P., Reda, D., Warren, S., Zieve, F., Wendell, W., Haroldson, J., Harper, P., Henderson, W. G., Henry, R. R., Kirkman, M. S., McCarren, M., Sacks, J., Gavin, J., Chew, E., Howard, B., Karrison, T., Pacold, I. V., Seigel, D., Vinicor, F., Massie, B., Goldman, S., Rapcsak, S., Sethi, G., Sharon, M., Thai, H., Zadina, K., Christensen, J., Morrison, D., Spooner, P., Westerband, A., Materson, B., Brinton, E., Klein, R., Colwell, J. A., Schaefer, E. J., Gass, C. S., Ehrmann, D. A., Rue, P., Schaefer, E. J., McNamara, J. R., Brophy, M., Humphries, D., Govan, D., McDonnell, L., Carlton, L., Weng, Y., Hayward, R. A., Krein, S., Goldman, S., Zadina, K., Soule, J., Caulder, S., Pittman, C., Alston, O., Mayfield, R. K., Moffitt, G., Sagel, J., Sanacor, F., Ganaway, E., Marks, J., Okur, L., Jones, L., Florez, H., Pfeifer, D., Samos, L., Taylor, A. L., Zimering, M. B., Sama, A., Rosenberg, F., Garcia, H., Ertel, N., Pogach, L., Shin, J. J., Caldarella, F., Carseli, C., Shah, M., Ginier, P., Arakel, G., Fu, Y., Tayloe, D., Allen, J. E., Fox, E., Hensley, P. G., Emanuele, N., Kahsen, K., Linnerud, P., Agrawal, L., Azad, N., Marcelli, M., Cunningham, G. R., Nichols, N. M., Cordero, E., Hijazi, R., Roman, F., Datta, P., Touza, M. G., Lteif, A., Moore, K. L., Lazar-Robinson, C., Gupta, S., Kirkman, M. S., Mendez, M., Haider, Z., Risley, L., Karounos, D., Barber, L., Hibbard, J., Anderson, J. W., Reynolds, L. R., Carlsen, J., Collins, R. W., Kashyap, M. L., Matheus, B., Rahbarnia, T., Vo, A. N., Downey, N., Fox, L., Gonzales, R. M., Meyers, C. D., Tavintharan, S., Nuttall, F. Q., Cupersmith, L., Dardick, K., Kollman, L., Georgopoulos, A., Niewoehner, C., Davis, N. S. N., Harper, P., Davis, D., Devin, J., Marney, A., Passyn-Dunn, J., Perkins, J., Stafford, J., Balch, L., Harris, P., Anderson, R. J., Dunning, D., Ludwig, S., Vogel, M., DeSouza, C., Ecklund, R., Doran, S., Korolchuk, C., McElmeel, M., Wagstaff, S., Reaven, P., Solie, B., Matchette, J., Meyer, C., Vela, S., Aslam, N., Brinton, E., Clark, J., Domb, A., McDonald, L., Shurtz, L., Rao, R. H., Beattie, J. N., Franko, C., DeRubertis, F. R., Kelly, D., Maser, M., Paul, J., Zieve, F., Clark, S. J., Grimsdale, A., Fredrickson, S., Levy, J., Schroeder, D., Iranmanesh, A., Dunn, B., Arsura, D., Kovesdy, C., Hanna, S., Iranmanesh, A., Florow, C., Remandaban, F., Smith, E., Henry, R. R., Keller, M., Aroda, V., Choe, C., Edelman, S., Gasper, A., MaFong, D., Mudaliar, S., Oh, D., Bandukwala, R., Chang, A., Chaudhary, S., Chinnapongse, S., Christiansen, L., Chu, N., Kim, D., Lupo, M., Chandran, M., Plodkowski, R., Sathyaprakash, R., Wilson, J., Yu, J., Macaraeg, G., Townes, S., DeFronzo, R., Johnson, L., Cusi, K., Tripathy, D., Bajaj, M., Blodgett, J., Kayshup, S., Vasquez, M. H., Walz, B., Weaver, T., Benabe, J., Mercado, Z., Padilla, B., Serrano-Rodriguez, J., Rosado, C., Mejias, E., Tejera, T., Geldrez, C., Gonzalez-Melendez, E., Natal, M., Jimenez, M. R., Shah, J. H., Wendel, W. S., Scott, L., Gurnsey, L. A., Kwiecinski, F. A., Boyden, T., Goldschmid, M. G., & Easton, V.
Affiliations
  • Edward Hines, Jr. VA Hospital (US)
  • Carl T. Hayden VA Medical Center, Phoenix, AZ
  • Cooperative Studies Program Coordinating Center, Edward Hines Jr. VA Hospital, Hines, IL
  • Endocrinology Section, Medical Service, Edward Hines Jr. VA Hospital, Hines, IL
Venue
Diabetes Care
Published
2019-09-23
Volume
42
Issue
11
Pages
e181-e182
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2974996295
Cited by
20
References
5
Citations by year
2026: 4 · 2025: 3 · 2024: 4 · 2023: 3 · 2022: 1 · 2021: 3 · 2020: 2
FWCI
1.16
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
tight glycemic control, type 2 diabetes, chronic kidney disease progression, end-stage renal disease, veterans, HbA1c, long-term renal outcomes, microvascular complications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review